Literature DB >> 18829283

Mechanisms of nuclear vitamin D receptor resistance in Harvey-ras-transfected cells.

Laura M Taber1, Lynn S Adams, Dorothy Teegarden.   

Abstract

The hormone 1,25 dihydroxyvitamin D (1,25(OH)(2)D) binds to the nuclear vitamin D receptor (nVDR), which heterodimerizes with retinoid X receptor alpha (RXRalpha), and this complex interacts with specific response elements [vitamin D response elements (VDREs)] to regulate gene transcription. Previous results show a significant reduction in 1,25(OH)(2)D-induced nVDR transcriptional activity in fibroblast (C3H10T1/2) cells transfected with the Harvey ras gene (ras cells) compared with parental cells. The purpose of this study was to investigate the mechanisms by which the H-ras gene interferes with nVDR transcriptional activity. Similar to the ras cells, transcriptional activity of the nVDR was reduced following induction of the H-ras gene for 9 days. The ras cells expressed similar protein levels of RXRalpha with the parent cells, and overexpression of the wild-type RXRalpha plasmid did not restore 1,25(OH)(2)D-mediated nVDR activity in ras cells. Inhibiting activation of extracellular signal-regulated kinase (ERK1/2) had no effect on nVDR activity in ras cells. Furthermore, the binding of nVDR to VDREs was reduced in 1,25(OH)(2)D-treated ras cells. In addition, neither treatment of ras cells with an inhibitor (ketoconazole) of the 1,25(OH)(2)D degradative enzyme, 24-hydroxylase, nor the protein kinase C inhibitors, bisindoylmaleimide I and Gö 6976, had an effect on nVDR activity. In contrast, inhibition of phosphatidylinositol 3-kinase (PI3K) with LY294002 resulted in a 1.6-fold significant increase in the nVDR activity in the ras cells. Taken together, these results indicate that PI3K may, at least in part, mediate the suppression of the 1,25(OH)(2)D regulation of nVDR transcriptional activity by the H-ras gene, leading to reduced ability to associate with response elements.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829283      PMCID: PMC2757168          DOI: 10.1016/j.jnutbio.2008.06.008

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  40 in total

1.  Novel phenotype of C3H 10T1/2 fibroblasts cotransfected with the c-Ha-ras and adenovirus 5 E1A oncogenes.

Authors:  E A Davenport; E J Taparowsky
Journal:  Mol Carcinog       Date:  1990       Impact factor: 4.784

2.  Altered phosphatidylcholine metabolism in C3H10T1/2 cells transfected with the Harvey-ras oncogene.

Authors:  D Teegarden; E J Taparowsky; C Kent
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

3.  H-ras gene mutations in salivary gland mucoepidermoid carcinomas.

Authors:  J Yoo; R A Robinson
Journal:  Cancer       Date:  2000-02-01       Impact factor: 6.860

4.  Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway.

Authors:  G S Reddy; K Y Tserng
Journal:  Biochemistry       Date:  1989-02-21       Impact factor: 3.162

5.  Metabolic pathways from 1 alpha,25-dihydroxyvitamin D3 to 1 alpha,25-dihydroxyvitamin D3-26,23-lactone. Stereo-retained and stereo-selective lactonization.

Authors:  S Ishizuka; A W Norman
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

6.  Role of protein kinase C in 1,25(OH)(2)-vitamin D(3) modulation of intracellular calcium during development of skeletal muscle cells in culture.

Authors:  D A Capiati; G Vazquez; M T Tellez Iñón; R L Boland
Journal:  J Cell Biochem       Date:  2000-03       Impact factor: 4.429

7.  Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.

Authors:  M O Bradley; A R Kraynak; R D Storer; J B Gibbs
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 8.  Sunlight--can it prevent as well as cause cancer?

Authors:  G P Studzinski; D C Moore
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

9.  1alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex.

Authors:  Z Hmama; D Nandan; L Sly; K L Knutson; P Herrera-Velit; N E Reiner
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

10.  Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase C.

Authors:  T B Vaidya; C M Weyman; D Teegarden; C L Ashendel; E J Taparowsky
Journal:  J Cell Biol       Date:  1991-08       Impact factor: 10.539

View more
  6 in total

Review 1.  Mechanisms of oncogene-induced genomic instability.

Authors:  Simona Graziano; Susana Gonzalo
Journal:  Biophys Chem       Date:  2016-11-24       Impact factor: 2.352

2.  Apc(MIN) modulation of vitamin D secosteroid growth control.

Authors:  Haibo Xu; Gary H Posner; Michael Stevenson; Frederick C Campbell
Journal:  Carcinogenesis       Date:  2010-05-20       Impact factor: 4.944

3.  1α, 25-Dihydroxyvitamin D regulates hypoxia-inducible factor-1α in untransformed and Harvey-ras transfected breast epithelial cells.

Authors:  Yan Jiang; Wei Zheng; Dorothy Teegarden
Journal:  Cancer Lett       Date:  2010-07-23       Impact factor: 8.679

4.  1,25-dihydroxyvitamin D regulation of glucose metabolism in Harvey-ras transformed MCF10A human breast epithelial cells.

Authors:  Wei Zheng; Fariba Tayyari; G A Nagana Gowda; Daniel Raftery; Eric S McLamore; Jin Shi; D Marshall Porterfield; Shawn S Donkin; Brian Bequette; Dorothy Teegarden
Journal:  J Steroid Biochem Mol Biol       Date:  2013-04-22       Impact factor: 4.292

5.  Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence.

Authors:  S Graziano; R Johnston; O Deng; J Zhang; S Gonzalo
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

6.  Vitamin D and Breast Cancer: Mechanistic Update.

Authors:  JoEllen Welsh
Journal:  JBMR Plus       Date:  2021-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.